| #114 |
Joseph Scheiwe |
— |
1 |
| #114 |
Christian Chatenay-Rivauday |
Novartis Ag |
1 |
| #114 |
Alessandro Lamonica |
— |
1 |
| #114 |
Jan Kendall DE KRUIF |
Tillotts Pharma Ag |
1 |
| #114 |
Nora Weber |
— |
1 |
| #114 |
Ludivine Labagnere |
— |
1 |
| #114 |
Marie-Eve Überschlag |
— |
1 |
| #114 |
Patrice Grosperrin |
Endress+Hauser Se+Co. Kg |
1 |
| #114 |
Bernard Starck |
— |
1 |
| #114 |
Philippe Thomas Lott |
Ansaldo Energia Switzerland Ag |
1 |
| #114 |
Virginie Casarotto |
Institut Pasteur |
1 |
| #114 |
Wolfgang Stankmann |
Kraft Foods R & D |
1 |
| #114 |
Emmanuel Pinard |
— |
1 |
| #114 |
Francois Gantz |
Roche Palo Alto |
1 |
| #114 |
Allan D'Arcy |
Greiner Bio-One Gmbh |
1 |
| #114 |
Olivier VALDENAIRE |
Actelion Pharmaceuticals |
1 |
| #114 |
Jean-Louis Hug |
Novartis Ag |
1 |
| #114 |
Francois Schilt |
Lalique |
1 |
| #114 |
Mathieu G. R. Turbioz |
Basf Se |
1 |
| #114 |
Yann Pressel |
Dsm Ip Assets B.V. |
1 |
| #114 |
Monica Contreras Dominguez |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
1 |
| #114 |
Geoffrey Denny |
Behr France Rouffach Sas |
1 |
| #114 |
Caroline Ploton |
Dsm Ip Assets B.V. |
1 |
| #114 |
Thierry Sifferien |
Actelion Pharmaceuticals |
1 |
| #114 |
Jacques Cercus |
Novartis Ag |
1 |
| #114 |
Linda Mindeholm |
Novartis Ag |
1 |
| #114 |
Auguste Ritter |
— |
1 |
| #114 |
Michel Dietz |
Hoffmann-La Roche |
1 |
| #114 |
Christian Walch |
Hoffmann-La Roche |
1 |
| #114 |
Matheiu G. R. Turbiez |
Basf Se |
1 |
| #114 |
Michel Gentner |
Sulzer Chemtech Ag |
1 |
| #114 |
Christophe Flesch |
CNRS |
1 |
| #114 |
Dider Letourneur |
Rhodia Operations |
1 |
| #114 |
Emilie Dupont |
Novartis Tiergesundheit Ag |
1 |
| #114 |
Lionel Doumampouom-Metoul |
Novartis Ag |
1 |
| #114 |
Loïc SIEBER |
Sca Tissue France |
1 |
| #114 |
René Bonnafous |
Hoffmann-La Roche |
1 |
| #114 |
Idriss El-Merdoui |
GE |
1 |
| #114 |
Angelique Hug |
Colgate-Palmolive |
1 |
| #114 |
Manuella Schmitt-Billet |
Polyphor Ag |
1 |